Awakn Life Sciences Corp. (AWKNF)
- Previous Close
0.1374 - Open
0.1380 - Bid --
- Ask --
- Day's Range
0.1350 - 0.1380 - 52 Week Range
0.0422 - 0.3600 - Volume
11,370 - Avg. Volume
14,075 - Market Cap (intraday)
6.285M - Beta (5Y Monthly) 2.74
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.
awaknlifesciences.comRecent News: AWKNF
Performance Overview: AWKNF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AWKNF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AWKNF
Valuation Measures
Market Cap
6.28M
Enterprise Value
5.88M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.15
Price/Book (mrq)
--
Enterprise Value/Revenue
3.77
Enterprise Value/EBITDA
-0.74
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-150.88%
Return on Equity (ttm)
-8,495.30%
Revenue (ttm)
1.56M
Net Income Avi to Common (ttm)
-7.32M
Diluted EPS (ttm)
-0.2000
Balance Sheet and Cash Flow
Total Cash (mrq)
554.66k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.2M
Research Analysis: AWKNF
Company Insights: AWKNF
AWKNF does not have Company Insights